What is the ticker symbol for CNS Pharmaceuticals?

CNS Pharmaceuticals trades under the ticker CNSP on NASDAQ.

What sector does CNS Pharmaceuticals operate in?

CNS Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CNSP in a portfolio?

PortView shows CNSP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

CNS Pharmaceuticals (CNSP) Stock Analysis

NASDAQHealthcareBiotechnology

$4.66-8.27%

1-year price historyRange $2.13 – $8.06

52-week range$4.66

$1.90$10.54

Track CNSP in your portfolio for free · Portfolio tracker

What CNS Pharmaceuticals does

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.

Key metrics

Market cap

$6.81M

P/E (TTM)

-0.25

EPS (TTM)

$-18.53

Beta

1.02

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$5.40

200-day avg

$4.61

52-week high

$10.54

52-week low

$1.90

CEO

Rami Levin

ETFs linked to CNSP

Broad-market and Healthcare sector ETFs an investor holding CNS Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CNSP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CNSP in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for CNS Pharmaceuticals?: CNS Pharmaceuticals trades under the ticker CNSP on NASDAQ.
Which exchange is CNSP listed on?: CNSP is listed on NASDAQ.
What sector does CNS Pharmaceuticals operate in?: CNS Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CNSP in a portfolio?: PortView shows CNSP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.